Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
Submitted by
admin
on June 30, 2014 - 8:55am
Source:
Yahoo/Reuters
News Tags:
FDA
Allergan
migraines
Semprana
Levadex
Valeant Pharmaceuticals
Headline:
Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
Do Not Allow Advertisers to Use My Personal information
